# TREACE MEDICAL CONCEPTS, INC. (TMCI) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from TREACE MEDICAL CONCEPTS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TMCI/mda/fy2025/): filed 2026-02-27; accession 0001193125-26-079167 (https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/tmci-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/TMCI/mda/fy2024/): filed 2025-02-27; accession 0000950170-25-029029 (https://www.sec.gov/Archives/edgar/data/1630627/000095017025029029/tmci-20241231.htm)
- [FY 2023 MD&A](/company/TMCI/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-021228 (https://www.sec.gov/Archives/edgar/data/1630627/000095017024021228/tmci-20231231.htm)
- [FY 2022 MD&A](/company/TMCI/mda/fy2022/): filed 2023-03-08; accession 0000950170-23-006603 (https://www.sec.gov/Archives/edgar/data/1630627/000095017023006603/tmci-20221231.htm)
- [FY 2021 MD&A](/company/TMCI/mda/fy2021/): filed 2022-03-04; accession 0000950170-22-002903 (https://www.sec.gov/Archives/edgar/data/1630627/000095017022002903/tmci-20211231.htm)

Back to /company/TMCI/